ME Quote, Financials, Valuation and Earnings

iSpecimen has a net margin of -134.11% compared to 23andMe Holding's net margin of -54.09%. 23andMe Holding's return on equity of -214.19% beat iSpecimen's return on equity of -118.86%.

23andMe Holding has a consensus price target of --, signalling upside risk potential of 156.27%. On the other hand iSpecimen has an analysts' consensus of -- which suggests that it could grow by 1900%. Given that iSpecimen has higher upside potential than 23andMe Holding, analysts believe iSpecimen is more attractive than 23andMe Holding.

23andMe Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iSpecimen has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

23andMe Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iSpecimen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. 23andMe Holding pays -- of its earnings as a dividend. iSpecimen pays out -- of its earnings as a dividend.

23andMe Holding quarterly revenues are $44.1M, which are larger than iSpecimen quarterly revenues of $2.7M. 23andMe Holding's net income of -$59.1M is lower than iSpecimen's net income of -$1.4M. Notably, 23andMe Holding's price-to-earnings ratio is -- while iSpecimen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for 23andMe Holding is 0.32x versus 0.16x for iSpecimen. Usually stocks with elevated PS ratios are considered overvalued.

Natera has a net margin of -134.11% compared to 23andMe Holding's net margin of -7.18%. 23andMe Holding's return on equity of -214.19% beat Natera's return on equity of -26.45%.

23andMe Holding has a consensus price target of --, signalling upside risk potential of 156.27%. On the other hand Natera has an analysts' consensus of $167.90 which suggests that it could grow by 3.54%. Given that 23andMe Holding has higher upside potential than Natera, analysts believe 23andMe Holding is more attractive than Natera.

23andMe Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Natera has a beta of 1.628, suggesting its more volatile than the S&P 500 by 62.789%.

23andMe Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Natera offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. 23andMe Holding pays -- of its earnings as a dividend. Natera pays out -- of its earnings as a dividend.

23andMe Holding quarterly revenues are $44.1M, which are smaller than Natera quarterly revenues of $439.8M. 23andMe Holding's net income of -$59.1M is lower than Natera's net income of -$31.6M. Notably, 23andMe Holding's price-to-earnings ratio is -- while Natera's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for 23andMe Holding is 0.32x versus 12.88x for Natera. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of -134.11% compared to 23andMe Holding's net margin of 3.64%. 23andMe Holding's return on equity of -214.19% beat Progyny's return on equity of 11.31%.

23andMe Holding has a consensus price target of --, signalling upside risk potential of 156.27%. On the other hand Progyny has an analysts' consensus of $30.22 which suggests that it could grow by 31.5%. Given that 23andMe Holding has higher upside potential than Progyny, analysts believe 23andMe Holding is more attractive than Progyny.

23andMe Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny has a beta of 1.350, suggesting its more volatile than the S&P 500 by 34.952%.

23andMe Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. 23andMe Holding pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

23andMe Holding quarterly revenues are $44.1M, which are smaller than Progyny quarterly revenues of $286.6M. 23andMe Holding's net income of -$59.1M is lower than Progyny's net income of $10.4M. Notably, 23andMe Holding's price-to-earnings ratio is -- while Progyny's PE ratio is 24.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for 23andMe Holding is 0.32x versus 1.24x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

RadNet has a net margin of -134.11% compared to 23andMe Holding's net margin of 0.7%. 23andMe Holding's return on equity of -214.19% beat RadNet's return on equity of -0.45%.

23andMe Holding has a consensus price target of --, signalling upside risk potential of 156.27%. On the other hand RadNet has an analysts' consensus of $68.17 which suggests that it could grow by 23.91%. Given that 23andMe Holding has higher upside potential than RadNet, analysts believe 23andMe Holding is more attractive than RadNet.

23andMe Holding has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison RadNet has a beta of 1.768, suggesting its more volatile than the S&P 500 by 76.83%.

23andMe Holding has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. RadNet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. 23andMe Holding pays -- of its earnings as a dividend. RadNet pays out -- of its earnings as a dividend.

23andMe Holding quarterly revenues are $44.1M, which are smaller than RadNet quarterly revenues of $461.1M. 23andMe Holding's net income of -$59.1M is lower than RadNet's net income of $3.2M. Notably, 23andMe Holding's price-to-earnings ratio is -- while RadNet's PE ratio is 444.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for 23andMe Holding is 0.32x versus 2.94x for RadNet. Usually stocks with elevated PS ratios are considered overvalued.